Irit Ben‐Aharon

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

Ruth Scherz‐Shouval, Sandro Santagata, Marc L. Mendillo et al. · Cell · 2014 · 416 citations · Full text

Malignant Disease, Medicine, Cancer Cell Biology +9

Doxorubicin-induced ovarian toxicity

Irit Ben‐Aharon, Hadas Bar‐Joseph, Galia Tzarfaty et al. · Reproductive Biology and Endocrinology · 2010 · 165 citations · Full text

Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer

Tal Goshen‐Lago, Ithai Waldhorn, Roy Holland et al. · JAMA Oncology · 2021 · 157 citations · Full text